Literature DB >> 17575483

Cardiovascular manifestations of myotonic dystrophy-1.

Ali A Sovari1, C Kenneth Bodine, Farhad Farokhi.   

Abstract

Myotonic dystrophy (DM) is an inherited disorder transmitted in an autosomal dominant fashion and characterized by myotonia with dystrophic involvement of muscles and other multisystemic manifestations. It is the most common muscular dystrophy in whites. DM1, the most common type of DM, is associated with conduction defects, tachyarrhythmia, cardiomyopathy, and other cardiac disorders such as valvular diseases. The conduction defects in patients with DM1 are progressive; therefore, these patients should undergo careful work-up and follow-up, even if presenting with a benign conduction defect such as first-degree atrioventricular block. Atrial tachyarrhythmias are the most common arrhythmias in DM1, although ventricular tachycardia (VT) with a bundle branch re-entry mechanism can also occur. Interestingly, such VT can be cured by right bundle branch ablation with no need for an implantable cardioverter defibrillator. A significant portion of DM1 patients have heart failure, which is not clinically apparent, in part, because of the limited ability for exertion. Therefore, a low threshold should be used regarding when evaluating the heart by echocardiogram. Cardiovascular manifestations of DM1 have several important aspects that require careful attention and knowledge of the current evidence to make the best treatment decision. This article reviews the relevant DM1 literature and provides suggestions for diagnosis and treatment of patients with DM1.

Entities:  

Mesh:

Year:  2007        PMID: 17575483     DOI: 10.1097/CRD.0b013e318070d1a7

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  18 in total

1.  Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Laura S Hemmy; John W Day
Journal:  J Neurol Sci       Date:  2014-04-13       Impact factor: 3.181

2.  QRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance.

Authors:  Saman Nazarian; David A Bluemke; Kathryn R Wagner; Menekhem M Zviman; Evrim Turkbey; Brian S Caffo; Monda Shehata; David Edwards; Barbara Butcher; Hugh Calkins; Ronald D Berger; Henry R Halperin; Gordon F Tomaselli
Journal:  Magn Reson Med       Date:  2010-07       Impact factor: 4.668

3.  The Mef2 transcription network is disrupted in myotonic dystrophy heart tissue, dramatically altering miRNA and mRNA expression.

Authors:  Auinash Kalsotra; Ravi K Singh; Priyatansh Gurha; Amanda J Ward; Chad J Creighton; Thomas A Cooper
Journal:  Cell Rep       Date:  2014-01-09       Impact factor: 9.423

4.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

5.  Systemic therapy in an RNA toxicity mouse model with an antisense oligonucleotide therapy targeting a non-CUG sequence within the DMPK 3'UTR RNA.

Authors:  Ramesh S Yadava; Qing Yu; Mahua Mandal; Frank Rigo; C Frank Bennett; Mani S Mahadevan
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

6.  PKC inhibition ameliorates the cardiac phenotype in a mouse model of myotonic dystrophy type 1.

Authors:  Guey-Shin Wang; Muge N Kuyumcu-Martinez; Satyam Sarma; Nitin Mathur; Xander H T Wehrens; Thomas A Cooper
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

7.  Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child.

Authors:  Marjan De Rademaeker; Willem Verpoest; Martine De Rycke; Sara Seneca; Karen Sermon; Sonja Desmyttere; Maryse Bonduelle; Josianne Van der Elst; Paul Devroey; Inge Liebaers
Journal:  Eur J Hum Genet       Date:  2009-04-15       Impact factor: 4.246

8.  Oral motor movements and swallowing in patients with myotonic dystrophy type 1.

Authors:  Beatriz Ercolin; Fernanda Chiarion Sassi; Laura Davison Mangilli; Lucia Iracema Zanotto Mendonça; Suelly Cecilia Olivan Limongi; Claudia Regina Furquim de Andrade
Journal:  Dysphagia       Date:  2013-03-05       Impact factor: 3.438

9.  Diffusion tensor imaging reveals widespread white matter abnormalities in children and adolescents with myotonic dystrophy type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Christopher J Bell; Ryan L Muetzel; Kelvin O Lim; John W Day
Journal:  J Neurol       Date:  2012-11-29       Impact factor: 4.849

10.  Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.

Authors:  Sumitava Dastidar; Debanjana Majumdar; Jaitip Tipanee; Kshitiz Singh; Arnaud F Klein; Denis Furling; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.